NeonMind Biosciences Inc.: NeonMind Reports Business Highlig

Completed concrete milestones in its strategy to become a leading psychedelic drug developer and specialty clinics operator. Developed clear drug development pathway for NEO-001, the industry's first psilocybin-based

Related Keywords

Oakville , Ontario , Canada , United States , Canadian , Rob Tessarolo , Dinesh Bhayana , Scott Eckstein Tim Regan , Robert Tessarolo , Amber Allen , Bioscript Solutions , Company Research , A Research , Drug Administration , Services Division , Development Advisory Board , Trademark Office , Strategic Communications , Translational Life Sciences Inc , Neonmind Biosciences Inc , Services Divisions , Canadian Securities Exchange , Srx Health Solutions , Health Solutions , Neonmind Biosciences , Medical Services , Investigational New Drug , United States Patent , Philippe Martin , Development Advisory , Specialty Clinics Advisory Board , Depository Trust Company , Translational Life Sciences , Vice President , Chief Executive Officer , Neonmind , Iosciences , Reports , Business , Highlights , Partnership , Activities , Linical , Pipeline , Corporate , Developments ,